Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Liabilities (2016 - 2025)

Nephros (NEPH) has 16 years of Total Liabilities data on record, last reported at $3.2 million in Q3 2025.

  • For Q3 2025, Total Liabilities rose 46.52% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, up 46.52%, while the annual FY2024 figure was $2.6 million, 25.06% down from the prior year.
  • Total Liabilities reached $3.2 million in Q3 2025 per NEPH's latest filing, up from $2.6 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $3.5 million in Q4 2023 and bottomed at $1.7 million in Q2 2023.
  • Average Total Liabilities over 5 years is $2.5 million, with a median of $2.5 million recorded in 2025.
  • Peak YoY movement for Total Liabilities: plummeted 48.5% in 2021, then skyrocketed 83.36% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $2.9 million in 2021, then dropped by 26.99% to $2.1 million in 2022, then skyrocketed by 65.39% to $3.5 million in 2023, then fell by 25.06% to $2.6 million in 2024, then rose by 23.47% to $3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $3.2 million in Q3 2025, $2.6 million in Q2 2025, and $2.5 million in Q1 2025.